Nu-Med Plus (NUMD) Stock Price & Analysis
NUMD Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.04
- Previous Close
- $0.01
- Volume
- N/A
- Average Volume (3M)
- 8,418
- Market Cap
- $601.55K
- Enterprise Value
- $911.93B
- Total Cash (Recent Filing)
- $5,409
- Total Debt (Recent Filing)
- $122.50K
- Price to Earnings (P/E)
- ―
- Beta
- 1.42
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Nu-Med Plus News
NUMD FAQ
What was Nu-Med Plus’s price range in the past 12 months?
What is Nu-Med Plus’s market cap?
When is Nu-Med Plus’s upcoming earnings report date?
Is Nu-Med Plus overvalued?
Does Nu-Med Plus pay dividends?
What is Nu-Med Plus’s EPS estimate?
How many shares outstanding does Nu-Med Plus have?
Which hedge fund is a major shareholder of Nu-Med Plus?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Nu-Med Plus
Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- William R. Colvin
- Employees
- 2
- Website
- www.nu-medplus.com
- Address
- 640 Belle Terre Road, Port Jefferson, NY, 11777, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 5 | 1 | 4 |
| Moving Averages | 1 | 0 | 11 |





